射血分数降低的心力衰竭的肾素-血管紧张素系统特征 - Suppr

Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.

作者信息

Pavo Noemi, Wurm Raphael, Goliasch Georg, Novak Johannes Franz, Strunk Guido, Gyöngyösi Mariann, Poglitsch Marko, Säemann Marcus D, Hülsmann Martin

出版信息

J Am Coll Cardiol. 2016 Dec 27;68(25):2912-2914. doi: 10.1016/j.jacc.2016.10.017.

DOI:10.1016/j.jacc.2016.10.017

PMID:28007153

Abstract

摘要

相似文献

Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭的肾素-血管紧张素系统特征

J Am Coll Cardiol. 2016 Dec 27;68(25):2912-2914. doi: 10.1016/j.jacc.2016.10.017.

Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.用于射血分数降低的心力衰竭或左心室功能障碍的肾素-血管紧张素-醛固酮系统阻滞剂：网状Meta分析。

Int J Cardiol. 2016 Feb 15;205:65-71. doi: 10.1016/j.ijcard.2015.12.010. Epub 2015 Dec 15.

From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5).从 ACEI/ARB 到 ARNI 在冠状动脉疾病和心力衰竭中的应用（第 2/5 部分）。

J Am Coll Cardiol. 2019 Aug 6;74(5):683-698. doi: 10.1016/j.jacc.2019.04.068.

The renin-angiotensin-aldosterone system and heart failure.肾素-血管紧张素-醛固酮系统与心力衰竭。

Cardiol Clin. 2014 Feb;32(1):21-32, vii. doi: 10.1016/j.ccl.2013.09.002.

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂与射血分数保留的心力衰竭患者死亡率的相关性。

JAMA. 2012 Nov 28;308(20):2108-17. doi: 10.1001/jama.2012.14785.

Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries.从射血分数降低的心力衰竭患者中获得肾素-血管紧张素-醛固酮系统（RAAS）抑制的最佳益处的时机：来自随机对照试验和注册研究的经验教训。

Int J Cardiol. 2014 Dec 20;177(3):731-3. doi: 10.1016/j.ijcard.2014.11.004. Epub 2014 Nov 5.

Renin-angiotensin-aldosterone system inhibition in heart failure with mid-ranged ejection fraction: A systematic review and meta-analysis.射血分数中等范围的心力衰竭患者中肾素-血管紧张素-醛固酮系统抑制：一项系统评价和荟萃分析。

Eur J Prev Cardiol. 2020 Dec;27(19):2371-2373. doi: 10.1177/2047487319841937. Epub 2019 Apr 9.

Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction.肾素-血管紧张素系统拮抗剂用于射血分数保留的心力衰竭缺乏确凿证据。

Evid Based Med. 2013 Dec;18(6):226-7. doi: 10.1136/eb-2013-101238. Epub 2013 Apr 12.

Effect of renin-angiotensin system inhibitors on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies.血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂对射血分数保留心力衰竭患者死亡率的影响：一项观察性队列和随机对照研究的荟萃分析。

Heart Fail Rev. 2017 Nov;22(6):775-782. doi: 10.1007/s10741-017-9637-0.

Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part I.射血分数降低的心力衰竭药物治疗基础：证据与实践，第一部分

J Cardiovasc Nurs. 2016 Mar-Apr;31(2):101-13. doi: 10.1097/JCN.0000000000000284.

引用本文的文献

Association of Elevated Serum Aldosterone Concentrations in Pregnancy with Hypertension.孕期血清醛固酮浓度升高与高血压的关联

Biomedicines. 2023 Nov 1;11(11):2954. doi: 10.3390/biomedicines11112954.

Poor Performance of Angiotensin II Enzyme-Linked Immuno-Sorbent Assays in Mostly Hypertensive Cohort Routinely Screened for Primary Aldosteronism.在主要为高血压人群中进行原发性醛固酮增多症常规筛查时，血管紧张素II酶联免疫吸附测定表现不佳。

Diagnostics (Basel). 2022 Apr 30;12(5):1124. doi: 10.3390/diagnostics12051124.

Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension.利钠肽与血压稳态：对MANP的启示，一种新型的用于高血压治疗的鸟苷酸环化酶A受体激活剂

Front Physiol. 2022 Feb 11;12:815796. doi: 10.3389/fphys.2021.815796. eCollection 2021.

Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study.盐皮质激素受体拮抗剂和血管紧张素转换酶抑制剂对糖尿病肾病患者血管紧张素谱的影响：一项探索性研究。

Diabetes Ther. 2021 Sep;12(9):2485-2498. doi: 10.1007/s13300-021-01118-7. Epub 2021 Aug 5.

Renin Feedback Is an Independent Predictor of Outcome in HFpEF.肾素反馈是射血分数保留的心力衰竭（HFpEF）预后的独立预测因素。

J Pers Med. 2021 May 3;11(5):370. doi: 10.3390/jpm11050370.

ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.ACE2、血管紧张素 1-7 和骨骼肌：COVID-19 时代的综述。

Clin Sci (Lond). 2020 Nov 27;134(22):3047-3062. doi: 10.1042/CS20200486.

Neprilysin as a Biomarker: Challenges and Opportunities.中性内肽酶作为一种生物标志物：挑战与机遇。

Card Fail Rev. 2020 Aug 14;6:e23. doi: 10.15420/cfr.2019.21. eCollection 2020 Mar.

Getting to the Heart and Soul of Chronic Kidney Disease.探寻慢性肾脏病的核心与本质

J Am Heart Assoc. 2020 Aug 4;9(15):e017427. doi: 10.1161/JAHA.120.017427. Epub 2020 Jul 22.

The renin-angiotensin-aldosterone system and its suppression.肾素-血管紧张素-醛固酮系统及其抑制作用。

J Vet Intern Med. 2019 Mar;33(2):363-382. doi: 10.1111/jvim.15454. Epub 2019 Feb 26.

The renin-angiotensin system: going beyond the classical paradigms.肾素-血管紧张素系统：超越经典范式

Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H958-H970. doi: 10.1152/ajpheart.00723.2018. Epub 2019 Feb 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献